Work

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

Year: 2002

Type: article

Study design: Observational Study

Source: Cancer Cell

DOI: 10.1016/s1535-6108(02)00096-x

Authors: Neil P. Shah, John M. Nicoll, Bhushan Nagar, Mercedes E. Gorre, Ronald L. Paquette, John Kuriyan, Charles L. Sawyers

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, University of California, Berkeley, Howard Hughes Medical Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Institute of General Medical Sciences

Award: Research Tranining in Cellular and Molecular Biology

OpenAlex ID: W2015616444

FWCI: 43.14

Cites: 32

Cited by: 1,619

Related to: 10